NeoGenomics, Inc. (NEO)
NeoGenomics Market Cap : 1.280B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AtriCure, Inc. | 1.622B |
| ADMA Biologics, Inc. | 3.831B |
| Krystal Biotech, Inc. | 7.594B |
| Alignment Healthcare, Inc. | 4.120B |
| Monte Rosa Therapeutics, Inc. | 1.448B |
Market Cap Related Metrics
| PS Ratio | 1.742 |
| PEG Ratio | -0.3283 |
| Price to Book Value | 1.530 |
| Price | 9.89 |
| Earnings Yield | -8.53% |
| PEGY Ratio | -0.3283 |